The finding of several molecular similarities between the TCGA p53 endometrial cancer group and both high grade serous tubo-ovarian cancer (HGSOC) and basal-like breast cancer, has sparked interest in the potential for therapeutics that target homologous recombination in these tumours (33, 34). Here, TP53 is linked to neoplasm.